Found 113 matching trials
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma PHASE2 The study is being conducted to evaluate the efficacy and safety of convers...
Show More Location
Shandong Cancer Hospital and Institute
Learn More & Join Trial
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma PHASE2 This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Neo-TACE-HAIC for BCLC B Stage HCC NA Hepatocellular carcinoma (HCC) patients is a common disease in the East Asi...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT N/A This multicenter retrospective study evaluated consecutive patients with la...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma N/A Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Show More Location
Chinese PLA General hospital
Learn More & Join Trial
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma PHASE1 This study is designed to evaluate the efficacy and safety of sintilimab-be...
Show More Location
Multiple Locations
Learn More & Join Trial
FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis PHASE2 Try FOLFOX-HAIC combining bevacizumab or cetuximab for initially unresectab...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria PHASE3 The purpose of this study is to evaluate the efficacy and safety of resecti...
Show More Location
Dongguan People's Hospital
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT PHASE2 This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial